PGIM Jennison Health Sciences Fund- Class Z (PHSZX) investicinio fondo vieneto kaina ir naujienos

PagrindinisPHSZX • Investiciniai fondai

PGIM Jennison Health Sciences Fund- Class Z

44,82 $

04-07 · USD · MUTF · Atsisakymas

Fidelity Select Biotechnology Portfolio

25,67 $

FBIOX0,23 %

Janus Henderson Global Life Sciences Fund Class T

77,95 $

JAGLX0,12 %

ProFunds Biotechnology UltraSector Fund Investor Class

71,81 $

BIPIX0,15 %

Rydex NASDAQ-100® 2x Strategy Fund Class A

597,72 $

RYVLX0,049 %

Fidelity Select Pharmaceuticals Portfolio

31,09 $

FPHAX0,26 %

Franklin Biotechnology Discovery Fund Class A

170,99 $

FBDIX0,11 %

PGIM Jennison Health Sciences Fund- Class A

33,85 $

PHLAX0,45 %

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

61,55 $

SHSAX0,016 %

PGIM Jennison Health Sciences Fund- Class R

30,74 $

PJHRX0,42 %

PGIM Jennison Health Sciences Fund- Class R6

45,34 $

PHLQX0,44 %

Investicinis fondas

Ankstesnė uždarymo kaina

44,62 $

Grąža nuo einamųjų metų pradžios

−5,52 %

Išlaidų rodiklis

0,88 %

Kategorija

Healthcare Sector Equity

„Morningstar“ įvertis

Grynasis turtas

722,95 mln. USD

Pelningumas

0,26 %

Pirminės apkrovos mokestis

Pradžios data

1999-06-30

Rinkos naujienos

Yahoo Finance

prieš 1 valandą

PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy

MarketBeat

prieš 21 minutę

HC Wainwright Lowers DeFi Technologies (NASDAQ:DEFT) Price Target to $2.00

S&P 500 Futures Climb in Premarket Trading; United Airlines, American Airlines Group Lead

The cease-fire mirage: Here’s why stock-market bulls may already be getting ahead of themselves

VOO vs. SPY — Which S&P 500 ETF Actually Wins for Long-Term Investors?

Defense supplier Arxis seeks to raise up to $1.06 billion in Nasdaq IPO